Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature
Neurology·MeSH: Myoclonus
Prevalence
700.0 / 100K
Incidence
48.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature?
There are 1 clinical trial targeting Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature tracked by BioSniper.
What is the prevalence of Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature?
The estimated prevalence of Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature is approximately 700.0 per 100,000 population.
Deep-dive into Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis